Evidence map›Paper›PMID 31666351›Full record

ArticleNeurology2019

Implementation of quality measures and patient-reported outcomes in an epilepsy clinic.

Lidia M V R Moura, Brandon Magliocco, John P Ney, Eric M Cheng, Gregory J Esper, Daniel B Hoch

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Inequities in Epilepsy: A Scoping Review.Neurology. Clinical practice · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lidia M V R MouraFrom the Department of Neurology (L.M.V.R.M., D.B.H.), Massachusetts General Hospital, Boston; American Academy of Neurology (B.M.), Minneapolis, MN; Department of Neurology (J.P.N.), Boston University, MA; Department of Neurology (E.M.C.), David Geffen School of Medicine, University of California, Los Angeles; and Department of Neurology (G.J.E.), Emory University, Atlanta, GA. lidia.moura@mgh.harvard.edu.
Brandon MaglioccoFrom the Department of Neurology (L.M.V.R.M., D.B.H.), Massachusetts General Hospital, Boston; American Academy of Neurology (B.M.), Minneapolis, MN; Department of Neurology (J.P.N.), Boston University, MA; Department of Neurology (E.M.C.), David Geffen School of Medicine, University of California, Los Angeles; and Department of Neurology (G.J.E.), Emory University, Atlanta, GA.
John P NeyFrom the Department of Neurology (L.M.V.R.M., D.B.H.), Massachusetts General Hospital, Boston; American Academy of Neurology (B.M.), Minneapolis, MN; Department of Neurology (J.P.N.), Boston University, MA; Department of Neurology (E.M.C.), David Geffen School of Medicine, University of California, Los Angeles; and Department of Neurology (G.J.E.), Emory University, Atlanta, GA.
Eric M ChengFrom the Department of Neurology (L.M.V.R.M., D.B.H.), Massachusetts General Hospital, Boston; American Academy of Neurology (B.M.), Minneapolis, MN; Department of Neurology (J.P.N.), Boston University, MA; Department of Neurology (E.M.C.), David Geffen School of Medicine, University of California, Los Angeles; and Department of Neurology (G.J.E.), Emory University, Atlanta, GA.
Gregory J EsperFrom the Department of Neurology (L.M.V.R.M., D.B.H.), Massachusetts General Hospital, Boston; American Academy of Neurology (B.M.), Minneapolis, MN; Department of Neurology (J.P.N.), Boston University, MA; Department of Neurology (E.M.C.), David Geffen School of Medicine, University of California, Los Angeles; and Department of Neurology (G.J.E.), Emory University, Atlanta, GA.
Daniel B HochFrom the Department of Neurology (L.M.V.R.M., D.B.H.), Massachusetts General Hospital, Boston; American Academy of Neurology (B.M.), Minneapolis, MN; Department of Neurology (J.P.N.), Boston University, MA; Department of Neurology (E.M.C.), David Geffen School of Medicine, University of California, Los Angeles; and Department of Neurology (G.J.E.), Emory University, Atlanta, GA.

Funding

COVID-19 and Acute Medical Care: Impact on Dementia PatientsR01AG062282 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI HSU, JOHN · 2018 to 2022
$4.5M
NIA NIH HHS R01 AG062282
6 · The paper itself

Abstract

objectiveTo see if systematic collection of patient-reported epilepsy quality measures can identify opportunities to improve care, and to examine the associations between these measures and physical and mental health.

methodsWe developed a patient-reported questionnaire for medication adherence, seizure frequency, medication side effects, and driving that included the Patient-Reported Outcome Measurement Information System-10 (PROMIS-10) (physical and mental health). We offered it to all adult patients seen twice in an epilepsy clinic (January 2017-January 2018). The questionnaire was available on the web as well as a tablet provided at appointment check-in. We used the first completed questionnaire to explore the relationship between patient-reported care quality and measures of physical and mental health.

resultsA total of 610 unique patients (15% of the total encounters) completed a survey. Respondents were comparable to nonrespondents. Respondents reported gaps in care or opportunities for quality improvement in 48.4% (n = 295) of the encounters. Of patients who reported at least 1 seizure per month over the previous 3 months, 55.2% (n = 100) reported problems with adherence, 30.0% (n = 131) reported having problems believed to be adverse reactions to anticonvulsants, and 15.2% (n = 41) reported driving. In addition, respondents who reported either seizures over the recent 3 months, nonadherence to treatment due to cost, or anticonvulsant-associated adverse effects had consistently worse physical and mental health (all

conclusionsSystematic collection of epilepsy quality measures endorsed by the American Academy of Neurology can identify opportunities for quality improvement. Measures of epilepsy care quality predict outcomes that matter to patients.

Indexed as

Patient Reported Outcome MeasuresQuality of Health CareAdultAnticonvulsantsAutomobile DrivingDrug-Related Side Effects and Adverse ReactionsEpilepsyFemaleHumansMaleMedication AdherenceMiddle AgedProspective StudiesQuality ImprovementSeizuresSurveys and QuestionnairesAnticonvulsants

Identifiers

PMID31666351
PMCPMC7978483

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.